Home/Filings/4/0001209191-12-050500
4//SEC Filing

Ozeroff Christopher David 4

Accession 0001209191-12-050500

CIK 0000907654other

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 8:00 PM ET

Size

6.7 KB

Accession

0001209191-12-050500

Insider Transaction Report

Form 4
Period: 2012-10-22
Ozeroff Christopher David
EVP & General Counsel
Transactions
  • Award

    Common Stock Warrant (right to buy)

    2012-10-22+47,60647,606 total
    Exercise: $0.30From: 2012-10-25Exp: 2017-10-25Common Stock (47,606 underlying)
  • Award

    Common Stock

    2012-10-22$0.39/sh+63,475$25,003105,233 total
Footnotes (1)
  • [F1]The warrants are fully vested and exercisable upon issuance and have a contractual term of 5 years.

Issuer

ARCA biopharma, Inc.

CIK 0000907654

Entity typeother

Related Parties

1
  • filerCIK 0001454996

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 8:00 PM ET
Size
6.7 KB